ArticleJournal of cellular and molecular medicine2026

Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer.

Sung Wan Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.